[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Pharmaceuticals Market Research Reports & Industry Analysis

Pharmaceuticals refer to compounds manufactured for use as a medicinal drug. Companies active in the pharmaceutical industry are involved in development, production and marketing of pharmaceuticals.

The global market for pharmaceuticals is demonstrating a substantial growth in Latin America and Asia, but is relatively stable in Europe. The worldwide market is assessed at about USD 300 billion yearly. The USA, Japan, Germany, France and China are the top pharmaceutical markets. The pharmaceutical industry benefits from the ageing population; new medical discoveries and new drugs approvals; the increased number of chronic, degenerative and heart diseases, and cancer.

The research reports of this Catalogue cover all the major categories within global, regional and local pharmaceuticals markets. The reports offer overviews of the market trends, drivers; factors contributing to market growth. The challenges faced by industry participants, analyses of the top companies involved in the marketplace, and the key market news are provided in the reports.

Publications found: 33,057
Sort by:

Vitamin and Provitamin Market in Qatar to 2022

US$ 603.13

... future outlook of the vitamin and provitamin market in Qatar to 2022 Track industry developments and identify market opportunities Plan and develop marketing, market-entry, market expansion, and other ...

March 2018 21 pages

Vitamin and Provitamin Market in Serbia to 2022

US$ 603.13

... future outlook of the vitamin and provitamin market in Serbia to 2022 Track industry developments and identify market opportunities Plan and develop marketing, market-entry, market expansion, and other ...

March 2018 21 pages

Vitamin and Provitamin Market in Switzerland to 2022

US$ 603.13

... future outlook of the vitamin and provitamin market in Switzerland to 2022 Track industry developments and identify market opportunities Plan and develop marketing, market-entry, market expansion, and other ...

March 2018 21 pages

Vitamin and Provitamin Market in Tanzania to 2022

US$ 603.13

... future outlook of the vitamin and provitamin market in Tanzania to 2022 Track industry developments and identify market opportunities Plan and develop marketing, market-entry, market expansion, and other ...

March 2018 21 pages

Vitamin and Provitamin Market in Trinidad and Tobago to 2022

US$ 603.13

... industry data incluided in this report: Demand for vitamins and provitamins, 2011-2022 Vitamin and provitamin market size by product type, 2011-2022 Growth rates ...

March 2018 21 pages

World Antibiotic Markets to 2022

US$ 23,743.56

... package World Antibiotic Markets to 2022 offers the most up-to-date industry data on the actual market situation, and future outlook for antibiotics in the world. Along with a global antibiotics market ...

March 2018 1501 pages

World Insulin Markets to 2022

US$ 23,743.56

... package World Insulin Markets to 2022 offers the most up-to-date industry data on the actual market situation, and future outlook for insulin in the world. Along with a global insulin market ...

March 2018 1027 pages

World Vaccine Markets to 2022

US$ 23,743.56

... package World Vaccine Markets to 2022 offers the most up-to-date industry data on the actual market situation, and future outlook for vaccines in the world. Along with a global vaccines market ...

March 2018 1027 pages

World Vitamin and Provitamin Markets to 2022

US$ 23,743.56

... market situation, and future outlook of the vitamin and provitamin market in the world to 2022 Track industry developments and identify market opportunities Plan and develop marketing, market-entry, market ...

March 2018 1659 pages

North America Botox Market by Manufacturers, Countries, Type and Application, Forecast to 2023

US$ 4,480.00

... to deeply display the North America Botox market. Chapter 1, to describe Botox Introduction, product type and application, market overview, market analysis by countries, market opportunities, market risk, market driving force; Chapter ...

March 2018 108 pages

North America Active Pharmaceutical Ingredients Market by Manufacturers, Countries, Type and Application, Forecast to 2023

US$ 4,480.00

... the Report: This report focuses on the Active Pharmaceutical Ingredients in North America market, especially in United States, Canada ... Chapters to deeply display the North America Active Pharmaceutical Ingredients market. Chapter 1, to describe Active Pharmaceutical Ingredients Introduction, product type and ...

March 2018 103 pages

Global Attention Deficit Hyperactivity Disorder (ADHD) Drug Industry Market Research 2017

US$ 2,600.00

... growth? 10. What are the Attention Deficit Hyperactivity Disorder (ADHD) Drug market opportunities and threats faced by the vendors in the global Attention Deficit Hyperactivity Disorder (ADHD) Drug market? Objective ...

March 2018 153 pages

Somatostatin Receptor Type 2 (SRIF1 or SSTR2) - Pipeline Review, H1 2018

US$ 3,500.00

... Somatostatin Receptor Type 2 (SRIF1 or SSTR2) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...

March 2018 66 pages

Collagenase 3 (Matrix Metalloproteinase 13 or MMP13 or EC 3.4.24.) - Pipeline Review, H1 2018

US$ 3,500.00

... Collagenase 3 (Matrix Metalloproteinase 13 or MMP13 or EC 3.4.24.) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...

March 2018 53 pages

Histone Deacetylase 6 (Protein Phosphatase 1 Regulatory Subunit 90 or HDAC6 or EC 3.5.1.98) - Pipeline Review, H1 2018

US$ 3,500.00

... Histone Deacetylase 6 (Protein Phosphatase 1 Regulatory Subunit 90 or HDAC6 or EC 3.5.1.98) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...

March 2018 115 pages

Cathepsin B (APP Secretase or Cathepsin B1 or CTSB or EC 3.4.22.1) - Pipeline Review, H1 2018

US$ 3,500.00

... Cathepsin B (APP Secretase or Cathepsin B1 or CTSB or EC 3.4.22.1) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...

March 2018 31 pages

CD40 Ligand (T Cell Antigen Gp39 or TNF Related Activation Protein or Tumor Necrosis Factor Ligand Superfamily Member 5 or CD154 or CD40LG) - Pipeline Review, H1 2018

US$ 3,500.00

... identifying key players and it’s most promising pipeline therapeutics Devise corrective measures for pipeline projects by understanding CD40 Ligand (T Cell Antigen Gp39 or TNF Related Activation Protein or Tumor Necrosis Factor Ligand Superfamily Member 5 or CD154 or CD40LG) development landscape Develop and ...

March 2018 66 pages

Estrogen Receptor (ER Alpha or Estradiol Receptor or Nuclear Receptor Subfamily 3 Group A Member 1 or NR3A1 or ESR1) - Pipeline Review, H1 2018

US$ 3,500.00

... effectively by identifying key players and it’s most promising pipeline therapeutics Devise corrective measures for pipeline projects by understanding Estrogen Receptor (ER Alpha or Estradiol Receptor or Nuclear Receptor Subfamily 3 Group A Member 1 or NR3A1 or ESR1) development landscape Develop and design ...

March 2018 81 pages

Estrogen Receptor Beta (ER Beta or Nuclear Receptor Subfamily 3 Group A Member 2 or NR3A2 or ESR2) - Pipeline Review, H1 2018

US$ 3,500.00

... Estrogen Receptor Beta (ER Beta or Nuclear Receptor Subfamily 3 Group A Member 2 or NR3A2 or ESR2) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...

March 2018 74 pages

Glial Cell Line Derived Neurotrophic Factor (Astrocyte Derived Trophic Factor or GDNF) - Pipeline Review, H1 2018

US$ 3,500.00

... reviews Glial Cell Line Derived Neurotrophic Factor (Astrocyte Derived Trophic Factor or GDNF) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...

March 2018 47 pages

Growth/Differentiation Factor 8 (Myostatin or GDF8 or MSTN) - Pipeline Review, H1 2018

US$ 3,500.00

... Growth/Differentiation Factor 8 (Myostatin or GDF8 or MSTN) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...

March 2018 69 pages

Hepatocyte Growth Factor (Hepatopoietin A or Scatter Factor or HGF) - Pipeline Review, H1 2018

US$ 3,500.00

... Hepatocyte Growth Factor (Hepatopoietin A or Scatter Factor or HGF) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...

March 2018 66 pages

Histone Deacetylase 1 (HDAC1 or EC 3.5.1.98) - Pipeline Review, H1 2018

US$ 3,500.00

... Histone Deacetylase 1 (HDAC1 or EC 3.5.1.98) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...

March 2018 138 pages

Histone Deacetylase 2 (Transcriptional Regulator Homolog RPD3 or YY1 Associated Factor 1 or HDAC2 or EC 3.5.1.98) - Pipeline Review, H1 2018

US$ 3,500.00

... effectively by identifying key players and it’s most promising pipeline therapeutics Devise corrective measures for pipeline projects by understanding Histone Deacetylase 2 (Transcriptional Regulator Homolog RPD3 or YY1 Associated Factor 1 or HDAC2 or EC 3.5.1.98) development landscape Develop and design ...

March 2018 120 pages

Histone Deacetylase 3 (SMAP45 or RPD3 2 or HDAC3 or EC 3.5.1.98) - Pipeline Review, H1 2018

US$ 3,500.00

... Histone Deacetylase 3 (SMAP45 or RPD3 2 or HDAC3 or EC 3.5.1.98) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...

March 2018 88 pages

Lysophosphatidic Acid Receptor 1 (Lysophosphatidic Acid Receptor Edg 2 or LPAR1) - Pipeline Review, H1 2018

US$ 3,500.00

... Lysophosphatidic Acid Receptor 1 (Lysophosphatidic Acid Receptor Edg 2 or LPAR1) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...

March 2018 36 pages

N-Formyl Peptide Receptor 2 (FMLP Related Receptor I or Formyl Peptide Receptor Like 1 or HM63 or Lipoxin A4 Receptor or RFP or FPR2) - Pipeline Review, H1 2018

US$ 3,500.00

... by identifying key players and it’s most promising pipeline therapeutics Devise corrective measures for pipeline projects by understanding N-Formyl Peptide Receptor 2 (FMLP Related Receptor I or Formyl Peptide Receptor Like 1 or HM63 or Lipoxin A4 Receptor or RFP or FPR2) development landscape Develop and ...

March 2018 27 pages

Nicotinamide Phosphoribosyltransferase (Visfatin or Pre B Cell Colony Enhancing Factor 1 or NAMPT or EC 2.4.2.12) - Pipeline Review, H1 2018

US$ 3,500.00

... effectively by identifying key players and it’s most promising pipeline therapeutics Devise corrective measures for pipeline projects by understanding Nicotinamide Phosphoribosyltransferase (Visfatin or Pre B Cell Colony Enhancing Factor 1 or NAMPT or EC 2.4.2.12) development landscape Develop and design ...

March 2018 51 pages

Orexin Receptor Type 1 (Hypocretin Receptor Type 1 or HCRTR1) - Pipeline Review, H1 2018

US$ 3,500.00

... Orexin Receptor Type 1 (Hypocretin Receptor Type 1 or HCRTR1) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...

March 2018 60 pages

Orexin Receptor Type 2 (Hypocretin Receptor Type 2 or HCRTR2) - Pipeline Review, H1 2018

US$ 3,500.00

... Orexin Receptor Type 2 (Hypocretin Receptor Type 2 or HCRTR2) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...

March 2018 64 pages

Transmembrane Prolyl 4 Hydroxylase (Hypoxia Inducible Factor Prolyl Hydroxylase 4 or P4HTM or EC 1.14.11.) - Pipeline Review, H1 2018

US$ 3,500.00

... Transmembrane Prolyl 4 Hydroxylase (Hypoxia Inducible Factor Prolyl Hydroxylase 4 or P4HTM or EC 1.14.11.) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...

March 2018 58 pages

Anti-Epileptic Drugs: Global Markets to 2022

US$ 1,375.00

... anti-epileptic drugs market Analyses of global market trends, with data from 2016 and 2017, and projections of compound annual growth rates (CAGRs) through 2022 Identification of segments ...

March 2018 161 pages

Anti-counterfeit Pharmaceuticals and Cosmetics-Asia Pacific Market Status and Trend Report 2013-2023

US$ 3,480.00

Report Anti-counterfeit Pharmaceuticals and Cosmetics-Asia Pacific Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Anti-counterfeit Pharmaceuticals and Cosmetics industry...

March 2018 131 pages

Anti-counterfeit Pharmaceuticals and Cosmetics-China Market Status and Trend Report 2013-2023

US$ 2,980.00

Report Anti-counterfeit Pharmaceuticals and Cosmetics-China Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Anti-counterfeit Pharmaceuticals and Cosmetics industry, stand...

March 2018 136 pages

Anti-counterfeit Pharmaceuticals and Cosmetics-EMEA Market Status and Trend Report 2013-2023

US$ 3,480.00

Report Anti-counterfeit Pharmaceuticals and Cosmetics-EMEA Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Anti-counterfeit Pharmaceuticals and Cosmetics industry, standi...

March 2018 141 pages

Anti-counterfeit Pharmaceuticals and Cosmetics-Europe Market Status and Trend Report 2013-2023

US$ 3,480.00

Report Anti-counterfeit Pharmaceuticals and Cosmetics-Europe Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Anti-counterfeit Pharmaceuticals and Cosmetics industry, stan...

March 2018 156 pages

Anti-counterfeit Pharmaceuticals and Cosmetics-Global Market Status and Trend Report 2013-2023

US$ 2,480.00

Report Anti-counterfeit Pharmaceuticals and Cosmetics-Global Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Anti-counterfeit Pharmaceuticals and Cosmetics industry, stan...

March 2018 133 pages

Anti-counterfeit Pharmaceuticals and Cosmetics-Global Market Status & Trend Report 2013-2023 Top 20 Countries Data

US$ 3,680.00

Report Anti-counterfeit Pharmaceuticals and Cosmetics-Global Market Status & Trend Report 2013-2023 Top 20 Countries Data offers a comprehensive analysis on Anti-counterfeit Pharmaceuticals and Cosm...

March 2018 132 pages

Anti-counterfeit Pharmaceuticals and Cosmetics-India Market Status and Trend Report 2013-2023

US$ 2,980.00

Report Anti-counterfeit Pharmaceuticals and Cosmetics-India Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Anti-counterfeit Pharmaceuticals and Cosmetics industry, stand...

March 2018 133 pages

Anti-counterfeit Pharmaceuticals and Cosmetics-North America Market Status and Trend Report 2013-2023

US$ 3,480.00

Report Anti-counterfeit Pharmaceuticals and Cosmetics-North America Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Anti-counterfeit Pharmaceuticals and Cosmetics industr...

March 2018 144 pages

Anti-counterfeit Pharmaceuticals and Cosmetics-South America Market Status and Trend Report 2013-2023

US$ 3,480.00

Report Anti-counterfeit Pharmaceuticals and Cosmetics-South America Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Anti-counterfeit Pharmaceuticals and Cosmetics industr...

March 2018 153 pages

Anti-counterfeit Pharmaceuticals and Cosmetics-United States Market Status and Trend Report 2013-2023

US$ 3,480.00

Report Anti-counterfeit Pharmaceuticals and Cosmetics-United States Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Anti-counterfeit Pharmaceuticals and Cosmetics industr...

March 2018 154 pages

Drugs for Infertility: Global Markets to 2022

US$ 1,375.00

... women and pharmaceutical drugs that enhance the reproductive fertility Insight into the type of infertility drugs, i.e., anti-estrogens and gonadotropins Profiles of major companies in the market, including Bayer ...

March 2018 167 pages

2018 U.S. Drugs, health aids, beauty aids sold through Other specialty food stores-Product & Retail Report

US$ 199.00

The 2018 U.S. Drugs, health aids, beauty aids sold through Other specialty food stores-Product & Retail Report, ... . The report features 2018 current and 2019 forecast estimates on the sales of Drugs, health aids, beauty aids nationally and for all 50 U.S. States and up to 900 metro ...

March 2018 93 pages

2018-2023 China Hyaluronic Acid Dermal Filler Market Report (Status and Outlook)

US$ 3,360.00

... , the Hyaluronic Acid Dermal Filler market size was xx million USD in China, and it will be xx million USD in 2023, with a CAGR of xx% between 2017 and 2023. In China market, the ...

March 2018 88 pages

2018-2023 Global Top Countries Hyaluronic Acid Dermal Filler Market Report

US$ 4,960.00

... USD, and it will be xx million USD in 2023, with a CAGR of xx% between 2017 and 2023. This report studies Hyaluronic Acid Dermal Filler in Global market ... , Middle East and Africa, focuses on the top Players in each country, covering Galderma Allergan Merz Sinclair LG Life Sciences Teoxane Market ...

March 2018 129 pages

2018-2023 India Hyaluronic Acid Dermal Filler Market Report (Status and Outlook)

US$ 3,360.00

... , the Hyaluronic Acid Dermal Filler market size was xx million USD in India, and it will be xx million USD in 2023, with a CAGR of xx% between 2017 and 2023. In India market, the ...

March 2018 88 pages

2018-2023 Malaysia Hyaluronic Acid Dermal Filler Market Report (Status and Outlook)

US$ 3,360.00

... , the Hyaluronic Acid Dermal Filler market size was xx million USD in Malaysia, and it will be xx million USD in 2023, with a CAGR of xx% between 2017 and 2023. In Malaysia market, the ...

March 2018 88 pages

2018-2023 Philippines Hyaluronic Acid Dermal Filler Market Report (Status and Outlook)

US$ 3,360.00

... , the Hyaluronic Acid Dermal Filler market size was xx million USD in Philippines, and it will be xx million USD in 2023, with a CAGR of xx% between 2017 and 2023. In Philippines market, the ...

March 2018 88 pages

2018-2023 UK Hyaluronic Acid Dermal Filler Market Report (Status and Outlook)

US$ 3,360.00

... is placed. In 2017, the Hyaluronic Acid Dermal Filler market size was xx million USD in UK, and it will be xx million USD in 2023, with a CAGR of xx% between ... 2017 and 2023. In UK market, the top players include Galderma Allergan ...

March 2018 88 pages

Filters

Search

Categories

23,521
914
8,559
40
23

Publishers

72
1
6
4
18
50
16
3
112
292
33
30
34
6,128
163
13
120
12
142
51
363
8
25
84
36
7
8
14
6
49
113
7
1
1,818
10
579
11
2,786
7
24
5,307
44
31
54
216
1,098
40
32
7
37
46
43
50
2,538
208
40
26
7
6
2
4
32
15
606
3,346
2,222
11
22
1
16
38
228
2
7
10
4
79
4
26
50
1
5
6
2
2
32
2
13
17
1
11
107
36
1
18
195
172
6
4
2
1
5
4
9
1
72
12
27
50
33
1
27
27
1
2
1
42
55
14
18
1
323
954
555
2
1
2
5
88
72
59
37
41
22
2
14
5
23
2
2

Regions

14
13
12
11
8
7
6
3
3
2
2
1
4
7
19
8
1,367
101
83
57
51
50
48
34
28
27
26
25
25
22
22
21
20
19
19
19
19
19
19
19
19
18
18
18
18
17
17
16
16
16
16
16
16
16
16
15
15
14
13
13
12
12
11
11
11
11
11
10
10
8
7
5
1,703
741
22
20
14
1,325
701
597
31
30
7
6
6
5
5
4
5
5
5
4
3
1
1
1
1
25
4
11
2
2
2
2
693
7
13
10
6
46
12
6
57
4
24,205

Price

Date

Pages

Offers

16
16
10
44
5
1
2